Clinical Trials on Granulomatous Disease, Chronic, X-linked
Total 34304 results
-
National Human Genome Research Institute (NHGRI)CompletedAutism | Asperger's Syndrome | Rett's DisorderUnited States
-
University of Mississippi Medical CenterCompletedAutistic Disorder | Rett Syndrome | Asperger Syndrome | Pervasive Developmental Disorder | Childhood Disintegrative DisorderUnited States
-
Denali Therapeutics Inc.CompletedMucopolysaccharidosis IIUnited Kingdom, United States, Netherlands
-
JCR Pharmaceuticals Co., Ltd.Active, not recruitingMucopolysaccharidosis IIJapan
-
ShireCompleted
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingHunter SyndromeUnited States, Germany, Malaysia, Philippines, Thailand, Dominican Republic, Serbia, Vietnam
-
JCR Pharmaceuticals Co., Ltd.Completed
-
JCR Pharmaceuticals Co., Ltd.Completed
-
Sangamo TherapeuticsTerminatedMucopolysaccharidosis II | MPS IIUnited States
-
REGENXBIO Inc.Withdrawn
-
Green Cross CorporationCompletedMucopolysaccharidosis IIKorea, Republic of
-
Eunice Kennedy Shriver National Institute of Child...University of MinnesotaCompleted
-
AO GENERIUMRecruitingMetabolic Diseases | Mucopolysaccharidosis Type IIRussian Federation
-
JCR Pharmaceuticals Co., Ltd.RecruitingMucopolysaccharidosis IIUnited States, Germany, Spain, France, Brazil, Argentina, Turkey, United Kingdom, Poland, Italy
-
Denali Therapeutics Inc.Enrolling by invitationMucopolysaccharidosis IIUnited States, Canada, Belgium, Czechia, Netherlands
-
Denali Therapeutics Inc.Active, not recruitingMucopolysaccharidosis IIUnited States, Netherlands, Canada, United Kingdom
-
JCR Pharmaceuticals Co., Ltd.Enrolling by invitationMucopolysaccharidosis IIUnited States
-
JCR Pharmaceuticals Co., Ltd.Completed
-
REGENXBIO Inc.CompletedMucopolysaccharidosis IIBrazil, United States, United Kingdom
-
REGENXBIO Inc.Enrolling by invitation
-
ArmaGen, IncCompletedMucopolysaccharidosis IIUnited States, Germany, Philippines
-
Baskent UniversityRecruitingIdiopathic Granulomatous MastitisTurkey
-
Janssen Pharmaceutical K.K.RecruitingX-Linked Retinitis PigmentosaJapan
-
Frontera TherapeuticsPeking Union Medical College Hospital; Eye & ENT Hospital of Fudan University; Henan Provincial People's HospitalRecruitingX-Linked Retinitis PigmentosaChina
-
Janssen Pharmaceutical K.K.CompletedX-Linked Retinitis PigmentosaJapan
-
TakedaRecruiting
-
TakedaAvailableHunter SyndromeUnited States, Australia, Mexico, Spain, United Kingdom
-
Green Cross CorporationCompleted
-
Medipol UniversityUnknownIdiopathic Granulomatous MastitisTurkey
-
NightstaRx Ltd, a Biogen CompanyCompletedChoroideremiaFinland, United States, Canada, Denmark, Netherlands, Germany, United Kingdom, Brazil, France
-
Hacettepe UniversityCompletedChewing Problem | Swallowing DisorderTurkey
-
Janssen Research & Development, LLCJanssen Research & Development, LLCActive, not recruitingX-Linked Retinitis PigmentosaUnited States, Canada, Israel, United Kingdom, Denmark, France, Belgium, Italy, Netherlands, Switzerland, Spain
-
BiogenCompletedX-Linked Retinitis PigmentosaUnited States, United Kingdom
-
4D Molecular TherapeuticsActive, not recruitingX-Linked Retinitis PigmentosaUnited States
-
Applied Genetic Technologies CorpCompletedX-Linked Retinitis PigmentosaUnited States
-
National Center for Research Resources (NCRR)University of California, San DiegoCompleted
-
University of ManchesterManchester University NHS Foundation Trust; Great Ormond Street Hospital for... and other collaboratorsRecruiting
-
GC Biopharma CorpRecruitingMucopolysaccharidosis II | Hunter SyndromeKorea, Republic of
-
Denali Therapeutics Inc.RecruitingMucopolysaccharidosis IIUnited States, Spain, United Kingdom, Czechia, France, Canada, Italy, Belgium, Netherlands, Germany, Argentina, Sweden, Turkey, Brazil, Colombia
-
Homology Medicines, IncWithdrawnMucopolysaccharidosis IIUnited States, Canada
-
JCR Pharmaceuticals Co., Ltd.Active, not recruitingMucopolysaccharidosis IIBrazil
-
ShireCompletedMucopolysaccharidosis IIUnited States, United Kingdom, Brazil, Germany
-
AO GENERIUMCompletedA Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy VolunteersMetabolic Diseases | Mucopolysaccharidosis Type IIRussian Federation
-
GlaxoSmithKlineCompletedMucopolysaccharidosis IIJapan
-
Green Cross CorporationUnknownMucopolysaccharidosis II
-
Uskudar UniversityRecruitingLesch-Nyhan SyndromeTurkey
-
ShireCompletedHunter SyndromeUnited States, Spain, Canada, United Kingdom, Mexico, Australia, France
-
Green Cross CorporationCompleted
-
ShireCompleted